Picture of Cosmos Pharmaceutical logo

3349 — Cosmos Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

Table: Cosmos Pharmaceutical -Q1 group results

Oct 13 (Reuters)-
Cosmos Pharmaceutical
CONSOLIDATED FINANCIAL HIGHLIGHTS

 (in billions of yen unless specified)

            3 months ended  3 months ended    Year to
            Aug 31, 2026    Aug 31, 2025   May 31, 2027
               LATEST         YEAR-AGO        LATEST
              RESULTS         RESULTS        FORECAST
Sales          286.65          272.39       1.19 trln
             (+5.2 pct)      (+4.0 pct)     (+8.2 pct)
Operating      12.01           11.65          43.00
             (+3.1 pct)      (+0.6 pct)     (+1.5 pct)
Recurring      12.77           12.19          45.70
             (+4.7 pct)      (-0.9 pct)     (+2.4 pct)
Net             8.25            8.17          30.70
             (+1.0 pct)      (+0.3 pct)     (-4.2 pct)
EPS          104.11 yen      103.10 yen     387.35 yen
Ann Div          --          82.00 yen      84.00 yen
-Q2 div          --          37.50 yen      42.00 yen
-Q4 div          --          44.50 yen      42.00 yen


 NOTE - Cosmos Pharmaceutical.

To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T

Recent news on Cosmos Pharmaceutical

See all news